NovoLabs
PrivateLast Round
Debt
Jun 19, 2025
Est. Valuation
$8.65M
Total Funding Raised
$605,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NovoLabs is a commercial products company that manufactures a patented Supercritical UV™ disinfection system for the effective treatment of process liquids and wastewaters.
Sector
Frontier & Industrial Tech
Verticals
Water Treatment, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoLabs Comparables
Compare NovoLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Van Remmen UV Technology | 78% | |
| Atlantium Technologies | 76% | |
| ULTRAAQUA | 73% |
NovoLabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 19, 2025 | ||||
| Series A | Feb 5, 2024 |
Key People
Founding team and executive leadership
NovoLabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2040 Ventures | Series A |
| Creative Destruction Lab | Series A, Accelerator |
| Massey Ventures | Series A, Accelerator |
| Kānoa – Regional Economic Development & Investment Unit | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 33% to 4.3K.
- Feb 5, 2024
$605K round led by 2040 Ventures and climatevcfund.
NovoLabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovoLabs's valuation, stock price, and market status.
Is NovoLabs a public or private company?
NovoLabs is a private company.
What is the current stock price of NovoLabs?
NovoLabs is a private company with no public stock price. No recent secondary market data is available.
How much is NovoLabs worth (valuation)?
NovoLabs's valuation is estimated at $8.6M based on funding round data.
Can I buy NovoLabs stock?
NovoLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NovoLabs's last funding round?
NovoLabs's most recent funding round was Debt on February 5, 2024.
Who are the main investors in NovoLabs?
Key investors in NovoLabs include 2040 Ventures, Massey Ventures, Kānoa – Regional Economic Development & Investment Unit.
Will NovoLabs IPO soon?
No public IPO plans have been announced for NovoLabs.
How can I track NovoLabs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovoLabs's secondary market activity and sign up for updates.